However, it also allows us to formulate the question of whether our findings could reflect an adaptation mechanism involving increased adiponectin levels to limit renal damage in SLE nephritis and could be used to plan other therapeutic strategies. This evidence concerns the gene ADIPOQ and lupus nephritis.